Indication
Herpes zoster
Herpes zoster, commonly known as shingles, is an acute neurocutaneous viral infection caused by the reactivation of latent varicella-zoster virus residing in dorsal root or cranial nerve ganglia following an initial episode of varicella. Read more about Herpes zoster
126 drugs 79 manufacturers
Drugs that treat it
Common Herpes zoster therapies.
VALACYCLOVIR (valacyclovir HCl)
ACYCLOVIR
ACYCLOVIR SODIUM
ACYCLOVIR
VALACYCLOVIR (valacyclovir HCl)
ACYCLOVIR
ACYCLOVIR
ACYCLOVIR
News & literature
Coming soonRelated codes
Coming soonRelated conditions & guidelines
Coming soonHerpes zoster, commonly known as shingles, is an acute neurocutaneous viral infection caused by the reactivation of latent varicella-zoster virus residing in dorsal root or cranial nerve ganglia following an initial episode of varicella.
It most frequently affects older adults and immunocompromised individuals due to a decline in virus-specific cell-mediated immunity.
Clinically, it presents with a painful, unilateral maculopapular rash that rapidly evolves into fluid-filled vesicles distributed along a single sensory dermatome, most commonly involving the thoracic or cranial nerve pathways.
The condition often causes significant neuropathic pain and may lead to complications such as postherpetic neuralgia or herpes zoster ophthalmicus.
- cdc.gov
Herpes zoster, commonly known as shingles, is an acute neurocutaneous viral infection caused by the reactivation of latent varicella-zoster virus residing in dorsal root or cranial nerve ganglia following an initial episode of varicella
- nih.gov
Herpes zoster, commonly known as shingles, is an acute neurocutaneous viral infection caused by the reactivation of latent varicella-zoster virus residing in dorsal root or cranial nerve ganglia following an initial episode of varicella It most frequently affects older adults and immunocompromised individuals due to a decline in virus-specific cell-mediated immunity
- nih.gov
It most frequently affects older adults and immunocompromised individuals due to a decline in virus-specific cell-mediated immunity
- cdc.gov
Clinically, it presents with a painful, unilateral maculopapular rash that rapidly evolves into fluid-filled vesicles distributed along a single sensory dermatome, most commonly involving the thoracic or cranial nerve pathways
- cdc.gov
Clinically, it presents with a painful, unilateral maculopapular rash that rapidly evolves into fluid-filled vesicles distributed along a single sensory dermatome, most commonly involving the thoracic or cranial nerve pathways
- nih.gov
Clinically, it presents with a painful, unilateral maculopapular rash that rapidly evolves into fluid-filled vesicles distributed along a single sensory dermatome, most commonly involving the thoracic or cranial nerve pathways
- cdc.gov
The condition often causes significant neuropathic pain and may lead to complications such as postherpetic neuralgia or herpes zoster ophthalmicus
- nih.gov
The condition often causes significant neuropathic pain and may lead to complications such as postherpetic neuralgia or herpes zoster ophthalmicus
- nih.gov
The condition often causes significant neuropathic pain and may lead to complications such as postherpetic neuralgia or herpes zoster ophthalmicus
Personalize your experience
Follow Herpes zoster and get updates as they land.
Already a member? Sign in
Follow an indication and get alerts when its drugs, labels, or guidelines change
Save any drug on this page to your favorites, synced across devices
AI-curated peer-reviewed research, summarized for your specialty
A morning digest of indication-relevant updates, when you want it
Sign in to follow this indication
Following an indication requires a free Physicians Office Resource account.